טוען...
Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies
Background Coeliac disease affects 1% of the population, but 75% remain undiagnosed. Objective To conduct a case finding feasibility and efficacy study for the detection of coeliac disease in community pharmacies. Setting Six community pharmacies across Sheffield, UK. Method A prospective study was...
שמור ב:
| הוצא לאור ב: | Int J Clin Pharm |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509084/ https://ncbi.nlm.nih.gov/pubmed/30778740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-019-00793-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|